Pages
Posts
- A cold virus could extend lives of some brain cancer patients, MD Anderson study finds
- A Phase I Study of a Tropism-Modified Conditionally Replicative Adenovirus for Recurrent Malignant Gynecologic Diseases
- Convergence of technology, immunotherapy and courage help U of M patient rise above life-threatening brain tumor
- CPRIT Provides $10.8M Grant to Advance Breakthrough Oncolytic Virus Therapy for Glioblastoma
- Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model
- DNX-2401 Demonstrates “Dramatic” Survival Benefit in Glioma
- DNX-2401 wins $2 million FDA grant for cancer immunotherapy
- Early Trial Shows ‘Smart Bomb’ Virus Extends Survival in Patients With Glioblastoma
- Examination of the Therapeutic Potential of Delta-24-RGD in Brain Tumor Stem Cells: Role of Autophagic Cell Death
- Human Bone Marrow–Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus Δ24-RGD to Human Gliomas
- Infectious enthusiasm
- Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas
- Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination
- Oncolytic Virotherapy for Malignant Gliomas
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients
- Potential of oncolytic viruses back on industry’s radar screen
- Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway
- Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma
- Re-engineered Cold Virus Increases Brain Cancer Patients’ Survival, Phase 1 Trial Shows
- Smart bomb virus shows promise as brain tumor immunotherapy
- The Common Cold as Cure?
- The Deadly Viruses Being Used To Combat Incurable Cancers
- The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
- Treating diffuse midline gliomas with an oncolytic virus